Journey Medical Corp Quarterly Cost of Revenue in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Journey Medical Corp quarterly/annual Cost of Revenue history and growth rate from Q3 2020 to Q3 2024.
  • Journey Medical Corp Cost of Revenue for the quarter ending September 30, 2024 was $5.29M, a 17.8% decline year-over-year.
  • Journey Medical Corp Cost of Revenue for the twelve months ending September 30, 2024 was $24.7M, a 13.1% decline year-over-year.
  • Journey Medical Corp annual Cost of Revenue for 2023 was $26.7M, a 13.4% decline from 2022.
  • Journey Medical Corp annual Cost of Revenue for 2022 was $30.8M, a 4.08% decline from 2021.
  • Journey Medical Corp annual Cost of Revenue for 2021 was $32.1M, a 120% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $24.7M $5.29M -$1.14M -17.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $25.8M $6.54M -$1.23M -15.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $27M $6.82M +$367K +5.69% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $26.7M $6.02M -$1.7M -22.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $28.4M $6.43M -$792K -11% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $29.2M $7.77M +$134K +1.76% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $29M $6.45M -$1.75M -21.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $30.8M $7.72M -$1.81M -19% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $32.6M $7.22M -$3.95M -35.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $36.5M $7.63M +$149K +1.99% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $36.4M $8.2M +$4.3M +110% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $32.1M $9.53M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $11.2M +$7.79M +230% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $7.48M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $3.91M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $3.38M Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.